New shot in the arm for leukemia patients Who've run out of options
Disease control
Recruiting now
This is the first study in people testing a new drug called CBX-250 for several types of advanced blood cancers that have come back or stopped responding to standard treatments. The main goal is to find a safe dose and see how well the body handles the drug, which is given as an …
Phase: PHASE1 • Sponsor: Crossbow Therapeutics, Inc. • Aim: Disease control
Last updated Mar 23, 2026 15:15 UTC